3 | SEC Filings Hub

Filing metadata

Accession number: 0001415889-22-007913
Form type: Form 3
Filer: NRX Pharmaceuticals, Inc.
CIK: CIK 1719406
Filed: Jul 22, 2022
Reporting period: Jul 12, 2022
Description: Initial ownership

Documents

0001415889-22-007913-index.htm

Complete submission

0001415889-22-007913.txt

directory listing

Filed by

NRX Pharmaceuticals, Inc.